On July 7th, NeuroXess initiated a GCP-registered clinical trial at Huashan Hospital, Fudan University, for its independently developed “Implantable Brain-Computer Interface System for Hand Movement Function Compensation.” This system is a fully implantable, fully wireless, and fully functional brain-computer interface system. The trial adopts a multi-center collaboration model, involving 15 top-tier hospitals in Shanghai and other regions. Its primary goal is to evaluate the safety and effectiveness of the system in restoring upper limb function in patients with quadriplegia resulting from cervical spinal cord injuries. According to reports, this marks the first subdural cortical surface implantable brain-computer interface product in China to enter the clinical registration phase for Class III medical devices, representing a significant leap forward in the transition of brain-computer interface technology from research exploration to large-scale clinical application in our nation.